IgA-nefropátia: vizsgálatok itt: Németország
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
- Where
- Aachen, Jena, Mainz
- Életkor
- 18 év and over
- People
- 347 worldwide
- Run by
- Takeda
See details and how to joinNCT06963827 · EU 2025-520825-19-00 - 3. fázisTaking peopleA clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have completed previous zigakibart trials
- Where
- Augsburg, Hanover, Jena, Magdeburg, Trier
- Életkor
- 18 év and over
- People
- 69 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-519638-22-00 · EU 2024-519638-22-00 - 2. fázisTaking peopleA Study to Assess the Effects of Zigakibart on IgA Nephropathy.
- Where
- Hanover, Mainz, Munich
- Életkor
- 18 év and over
- People
- 32 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07146906 · EU 2024-519699-24-00 - 3. fázisTaking peopleA Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
- Where
- Berlin, Brunswick, Dresden, Frankfurt Am Main, Hamburg, Heidelberg, Leipzig, Mainz, Stuttgart, Villingen-Schwenningen
- Életkor
- 18 év and over
- People
- 454 worldwide
- Run by
- Biogen
See details and how to joinNCT06935357 · EU 2024-519345-30-00 - 3. fázisTaking peopleA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Aachen, Berlin, Dresden, Essen, Freiburg im Breisgau, Hanover, Kiel, Magdeburg, Mainz, Stuttgart, Tuebingen, Ulm
- Életkor
- 18 év to 100 év
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - 2. fázisTaking peopleStudy of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Where
- Cologne, Hamburg, Heidelberg
- Életkor
- 1 év to 17 év
- People
- 67 worldwide
- Run by
- Travere Therapeutics, Inc.
See details and how to joinNCT05003986 · EU 2023-505497-14-00 - 2/3. fázisCsak meghívásosTrial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
- Where
- Dresden, Mainz
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT05248659